Peccatori, N., Arnaboldi, S., Leoni, V., Gaspari, S., Parasole, R., Santoro, N., Pellegrinelli, C., Bertorello, N., Mattera, R., Chiocca, E., Russo, D., Schumacher, R. F., Guardo, D., Spirito, A., Mura, R., Lovaste, S., Monterisi, S., Mazzara, C., Fazio, G., Valsecchi, M., Lorenzo, P. D., Sala, A., Colombini, A., Spinelli, M., Gotti, G., Bettini, L., Biondi, A., Conter, V., Balduzzi, A., Rizzari, C. (2025). Increased incidence of delayed methotrexate elimination in pediatric patients with Philadelphia-chromosome positive (Ph+) or ABL-class fusion positive (ABL-Class) acute lymphoblastic leukemia treated with imatinib: Results of a retrospective cohort study by the italian association of pediatric hematology-oncology (AIEOP). Blood. https://doi.org/10.1182/blood-2025-5095